Similar articles for PMID: 33219159

Year	Number of Results
1985	1
1994	3
1995	1
1996	3
1997	3
1998	7
1999	2
2000	5
2001	5
2002	5
2003	3
2004	4
2005	2
2006	6
2007	4
2008	4
2009	4
2010	1
2011	5
2012	3
2013	4
2014	6
2015	5
2016	3
2017	2
2018	4
2019	5
2020	3
2021	1

1

Management of challenging radioiodine treatment protocols: a case series and review of the literature.

Waller J, Lawhn-Heath CA, Edmonds C, Wendorf C, Holmes B, White M, Pampaloni M, Liu C, Flavell RR. Waller J, et al. J Nucl Med Technol. 2020 Nov 20:jnmt.120.255307. doi: 10.2967/jnmt.120.255307. Online ahead of print. J Nucl Med Technol. 2020. PMID: 33219159

2

Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.

Modarresifar H, Almodovar S, Bass WB, Ojha B. Modarresifar H, et al. Health Phys. 2007 Feb;92(2 Suppl):S45-9. doi: 10.1097/01.HP.0000252849.68617.50. Health Phys. 2007. PMID: 17228187

3

[Management of iodine-131 ablation therapy for thyroid carcinoma in a patient on chronic hemodialysis].

Zenasni N, Elkhayat S, Taleb S, Zamd M, Medkouri G, Benghanem Gharbi M, Ramdani B, Aschawa H, Guensi A. Zenasni N, et al. Nephrol Ther. 2015 Apr;11(2):114-7. doi: 10.1016/j.nephro.2014.11.007. Epub 2015 Feb 21. Nephrol Ther. 2015. PMID: 25709102 French.

4

Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.

Shimon I, Kneller A, Olchovsky D. Shimon I, et al. Clin Endocrinol (Oxf). 1995 Nov;43(5):651-4. doi: 10.1111/j.1365-2265.1995.tb02932.x. Clin Endocrinol (Oxf). 1995. PMID: 8548952 Review.

5

Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.

de Keizer B, Hoekstra A, Konijnenberg MW, de Vos F, Lambert B, van Rijk PP, Lips CJ, de Klerk JM. de Keizer B, et al. J Nucl Med. 2004 Sep;45(9):1549-54. J Nucl Med. 2004. PMID: 15347723 Free article. Clinical Trial.

6

Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure.

Yeyin N, Cavdar I, Uslu L, Abuqbeitah M, Demir M. Yeyin N, et al. Nucl Med Commun. 2016 Mar;37(3):283-7. doi: 10.1097/MNM.0000000000000439. Nucl Med Commun. 2016. PMID: 26619394

7

Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy.

Kaptein EM, Levenson H, Siegel ME, Gadallah M, Akmal M. Kaptein EM, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3058-64. doi: 10.1210/jcem.85.9.6813. J Clin Endocrinol Metab. 2000. PMID: 10999786 Clinical Trial.

8

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F. Luster M, et al. Endocr Relat Cancer. 2005 Mar;12(1):49-64. doi: 10.1677/erc.1.00830. Endocr Relat Cancer. 2005. PMID: 15788638 Review.

9

Disposition of radioiodine (131)I therapy for thyroid carcinoma in a patient with severely impaired renal function on chronic dialysis: a case report.

Magné N, Magné J, Bracco J, Bussière F. Magné N, et al. Jpn J Clin Oncol. 2002 Jun;32(6):202-5. doi: 10.1093/jjco/hyf049. Jpn J Clin Oncol. 2002. PMID: 12110636

10

Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.

Bal CS, Kumar A, Pant GS. Bal CS, et al. Nucl Med Commun. 2003 Feb;24(2):203-8. doi: 10.1097/00006231-200302000-00013. Nucl Med Commun. 2003. PMID: 12548045 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed